188 related articles for article (PubMed ID: 12926085)
1. Immunohistochemical analysis of a primary ovarian leiomyosarcoma. Case report.
Mayerhofer K; Lozanov P; Bodner K; Bodner-Adler B; Mayerhofer-Gallenbacher N; Hudelist G; Czerwenka K
Anticancer Res; 2003; 23(4):3433-6. PubMed ID: 12926085
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 expression in a primary leiomyosarcoma of the ovary: a case report.
Bodner K; Bodner-Adler B; Czerwenka K; Hudelist G; Kimberger O; Leodolter S; Mayerhofer K
Wien Klin Wochenschr; 2003 Mar; 115(5-6):191-5. PubMed ID: 12741081
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian carcinoma.
Gadducci A; Viacava P; Cosio S; Cecchetti D; Fanelli G; Fanucchi A; Teti G; Genazzani AR
Anticancer Res; 2003; 23(3C):3001-8. PubMed ID: 12926153
[TBL] [Abstract][Full Text] [Related]
4. Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors.
Del Carmen MG; Smith Sehdev AE; Fader AN; Zahurak ML; Richardson M; Fruehauf JP; Montz FJ; Bristow RE
Cancer; 2003 Oct; 98(8):1658-63. PubMed ID: 14534882
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation.
Belotti D; Paganoni P; Manenti L; Garofalo A; Marchini S; Taraboletti G; Giavazzi R
Cancer Res; 2003 Sep; 63(17):5224-9. PubMed ID: 14500349
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features of ovarian carcinosarcomas: a single institution experience.
Zorzou MP; Markaki S; Rodolakis A; Kastritis E; Bozas G; Dimopoulos MA; Papadimitriou CA
Gynecol Oncol; 2005 Jan; 96(1):136-42. PubMed ID: 15589592
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner-Adler B; Bodner K; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
[TBL] [Abstract][Full Text] [Related]
8. Primary ovarian fibrosarcoma with long-term survival: a report of two cases.
Choi WJ; Ha MT; Shin JK; Lee JH
J Obstet Gynaecol Res; 2006 Oct; 32(5):524-8. PubMed ID: 16984523
[TBL] [Abstract][Full Text] [Related]
9. Primary myxoid leiomyosarcoma of the ovary. A case report with review of the literature.
Trabelsi A; Mutijima E; El Hossini Soua A; Gassoumi M; Bouguizane S; Mokni M; Yacoubi MT; Korbi S
Tunis Med; 2005 May; 83(5):288-91. PubMed ID: 16044903
[TBL] [Abstract][Full Text] [Related]
10. The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.
Akhan SE; Yavuz E; Tecer A; Iyibozkurt CA; Topuz S; Tuzlali S; Bengisu E; Berkman S
Gynecol Oncol; 2005 Oct; 99(1):36-42. PubMed ID: 15992918
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic property of acrogranin in human uterine leiomyosarcoma: direct evidence of genetic contribution in in vivo tumorigenesis.
Matsumura N; Mandai M; Miyanishi M; Fukuhara K; Baba T; Higuchi T; Kariya M; Takakura K; Fujii S
Clin Cancer Res; 2006 Mar; 12(5):1402-11. PubMed ID: 16533762
[TBL] [Abstract][Full Text] [Related]
12. Leiomyosarcoma of the vulva. A case report.
Lösch A; Joura EA; Stani J; Breitenecker G; Lahodny J
J Reprod Med; 2001 Jun; 46(6):609-12. PubMed ID: 11441690
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas.
Ueda M; Hung YC; Terai Y; Kanda K; Kanemura M; Futakuchi H; Yamaguchi H; Akise D; Yasuda M; Ueki M
Clin Cancer Res; 2005 May; 11(9):3225-32. PubMed ID: 15867217
[TBL] [Abstract][Full Text] [Related]
14. Neuron-specific enolase-producing leiomyosarcoma of the mesentery.
Fukunaga M
APMIS; 2004 Feb; 112(2):105-8. PubMed ID: 15056226
[TBL] [Abstract][Full Text] [Related]
15. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
[TBL] [Abstract][Full Text] [Related]
16. Leiomyosarcoma arising from soft tissue tumor of the mediastinum.
Hirano H; Kizaki T; Sashikata T; Maeda T; Yoshii Y
Med Electron Microsc; 2003 Mar; 36(1):52-8. PubMed ID: 12658352
[TBL] [Abstract][Full Text] [Related]
17. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
18. Primary omental gastrointestinal stromal tumor (GIST).
Todoroki T; Sano T; Sakurai S; Segawa A; Saitoh T; Fujikawa K; Yamada S; Hirahara N; Tsushima Y; Motojima R; Motojima T
World J Surg Oncol; 2007 Jun; 5():66. PubMed ID: 17565683
[TBL] [Abstract][Full Text] [Related]
19. Effusion cytodiagnosis of carcinosarcoma derived from the female genital tract: immunohistochemical features of MMP-7 and Ki-67 and immunofluorescence double staining analyses of eight cases.
Ikeda K; Tate G; Suzuki T; Mitsuya T
Gynecol Oncol; 2005 May; 97(2):323-9. PubMed ID: 15863125
[TBL] [Abstract][Full Text] [Related]
20. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
